Tube Investments of India LtdQ3 FY25
Tube Investments of India Ltd Q3 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹3,258P/E: 92.3Market Cap: ₹57.1K CrSector: Auto Components
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026.
- →Capex of Rs. 300-400 Crores planned for base business expansion.
- →Additional Rs. 300-400 Crores capex targeted for growth initiatives in TI Medical, 3xper, and related ventures.
- →Rs. 200-300 Crores earmarked for potential M&A or new business lines to boost growth.
- →TI Medical aims for a 25% CAGR growth, adding new verticals beyond sutures.
- →EV segment: 50%+ market share in electric trucks pan-India with product launches including swap technology and new variants to drive volume growth.
- →Three-wheeler EV volumes expected to pick up from Q4 after product improvements.
- →Engineering division volume growth about 10% YoY; capacity utilization at 80-85%, with new plants increasing capacity for 1-2 years.
- →Overall long-term thesis intact, targeting sustained double-digit growth over 5-10 years.
Margin guidance
Category 3- →Standalone business revenue growth expected around 10%; PBT growth projected between 12%-15%.
- →TI Medical targeted for 25% CAGR growth including new vertical additions.
- →Engineering division volume growth approx. 10% year-on-year.
- →Electric vehicle (EV) business confident with 50%+ market share in pan-India electric trucks; volumes growing steadily.
- →Overall consolidated profit before tax increased by about 7.7% compared to the corresponding quarter last year.
- →Base business capex planned at Rs. 300-400 Crores; TI Medical/3xper and others an additional Rs. 300-400 Crores; potential Rs. 200-300 Crores for M&A and new lines.
- →Long-term outlook remains positive with a fundamental thesis of strong growth and profitability.
- →Management maintains confidence in maintaining double-digit growth over the medium to long term.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →No explicit mention of new fundraising through either debt or equity in the transcript.
- →Debt has been completely repaid as mentioned by Vellayan Subbiah.
- →Capital allocation plans mainly involve internal funding for capex and operational working capital.
- →Planned investments include:
- → - Rs. 300-400 Crores capex for the standalone/base business.
- → - Rs. 300-400 Crores for growth in TI Medical and 3xper businesses.
- → - Up to Rs. 200-300 Crores possibly allocated for M&A and new lines of business.
- →Any inorganic growth or new line of business requiring capital may lead to more capital being deployed.
- →No direct mention of raising fresh debt or equity at this time.
Order book
- →Engineering division is running at 80% to 85% capacity utilization, with new plants at Nasik and Phaltan starting operations recently, providing capacity for the next 1-2 years.
- →Railway business has a strong order book with expected revenue growth starting Q4 FY2026, though there is a one-quarter delay due to other suppliers’ supply chain readiness; TI’s readiness is confirmed.
- →TI Clean Mobility's electric vehicle segment has existing orders with 300+ trucks already running, and new product launches planned, indicating a healthy order pipeline.
- →Medical devices and 3xper have ongoing investments with planned capex and expected growth, indicating committed orderbook and work-in-progress.
- →No specific quantitative orderbook figures disclosed, but operational and strategic readiness points to strong pending orders and order inflow across key segments.
Capex plans
Yes- →**Next Year Capex Plans:**
- → - Rs. 300-400 Crores for standalone (base) business expansion.
- → - Rs. 300-400 Crores planned for growth areas including TI Medical (Greenfield) and 3xper Innoventure.
- → - Additional Rs. 200-300 Crores may be allocated for M&A activities in related new lines of business.
- → - Investment in TI Clean Mobility to be decided later in the year.
- →**3xper Innoventure:**
- → - Total planned investment of Rs. 300 Crores.
- → - Rs. 200 Crores invested till last year.
- → - Rs. 50 Crores invested this year (Q1 and Q2).
- → - Remaining Rs. 50 Crores to be deployed this year.
- →**TI Medical:**
- → - Investments focused on new medical lines beyond sutures.
- → - Growth driven by operational and capital investments.
- →**Strategic Focus:**
- → - Capital deployment aligned with long-term growth and profitability targets.
- → - Emphasis on both organic expansion and inorganic growth through M&A.
How does Tube Investments of India Ltd rank vs peers in Auto Components?
Pro feature1Tube Investments of India Ltd
Rev 3Mar 3
See full Auto Components sector rankings
Want more stocks like Tube Investments of India Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio